FDA Adverse Event Other Summary report: N

ARCHITECT ANTI-HBS

MDR report key: 1050185 · Received May 22, 2008

Report

Report Number
1415939-2008-00071
Event Type
Other
Date Received
May 22, 2008
Date of Event
May 6, 2008
Report Date
May 16, 2008
Manufacturer
ABBOTT LABORATORIES
Product Code
LOM
PMA / PMN Number
P050051
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TU
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION IN PROCESS, NO CONCLUSION CAN BE DRAWN. THE BASIS FOR THIS REPORT IS THAT THERE IS A SIMILAR PRODUCT MARKETED IN THE UNITED STATES (US). THE US PRODUCT LIST NUMBER IS 1L82 AND IS MARKETED AS ARCHITECT AUSAB. THIS PRODUCT MEETS THE CRITERIA FOR A 5-DAY MDR AS DESCRIBED IN THE FDA'S NOTICE DATED APRIL 8, 2008 [TO MANUFACTURERS AND INITIAL DISTRIBUTORS OF MEDICAL DEVICES THAT MAY CONTAIN HEPARIN OR ARE HEPARIN-COATED], AND ABBOTT IS SUBMITTING THIS 5-DAY MDR. OUR INVESTIGATION INTO THIS EVENT IS ONGOING AND A SUPPLEMENTAL MDR WILL BE SUBMITTED AT THE CONCLUSION OF OUR INVESTIGATION.

Description of Event or Problem · 1

THE ACCOUNT STATED, THE ARCHITECT ANTI-HBS ASSAY IS GENERATING UNEXPECTED REACTIVE RESULTS. THE SAME ARCHITECT ANTI-HBS SPECIMENS TEST AXSYM AUSAB NEGATIVE. THE ARCHITECT ANTI-HBS CONTROLS ARE IN RANGE. THE ACCOUNT USED SERUM SAMPLES FOR TESTING. THE REACTIVE ARCHITECT ANTI-HBS RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. NO IMPACT TO PT MANAGEMENT WAS REPORTED. HBSAG = 14.65 (NO UNITS OF MEASURE GIVEN, METHOD UNK). ARCHITECT ANTI-HBS = 24.02 MIU/ML REACTIVE. AXSYM AUSAB = 0.4 MIU/ML NEGATIVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT ANTI-HBS CMIA FOR THE QUANTITATIVE DETERMINATION OF ANTIBODY TO HEPATITIS B SURFACE ANTIG LOM ABBOTT LABORATORIES NA 51297M100

Patients

Seq Age Sex Outcome Treatment
1 UNK ARCHITECT ANALYZER, LIST 3M74-01